HER3/ErbB3 Antibody [N12M8]

N° de catalogue F4189

Imprimer

Description biologique

Spécificité HER3/ErbB3 Antibody [N12M8] détecte les niveaux endogènes de la protéine HER3/ErbB3 totale.
Contexte HER3/ErbB3 est un membre « pseudokinase » catalytiquement inactif de la famille des récepteurs Protein Tyrosine Kinase ErbB/HER, rendu intrinsèquement inactif par des substitutions clés dans son domaine kinase, mais capable d'une signalisation robuste par hétérodimérisation avec des membres actifs de la famille tels que HER2 ou EGFR. HER3 comprend un domaine extracellulaire (ECD) avec quatre sous-domaines : riches en leucine I/III pour la liaison à haute affinité de la neuréguline (NRG1/2) et riches en cystéine II/IV, le sous-domaine II abritant un bras de dimérisation ; une unique hélice α transmembranaire ; une région juxtamembranaire ; un domaine kinase atypique (hélice αC raccourcie, configuration inactive malgré la liaison ATP) ; et une queue C-terminale contenant au moins 9 à 11 sites tyrosine (notamment Tyr1222 et Tyr1289 dans les motifs YXXM) pour l'ancrage d'adaptateurs. Lors de la liaison du ligand, l'ECD de HER3 subit un changement conformationnel qui expose la boucle de dimérisation, favorisant la formation d'hétérodimères asymétriques, le plus puissamment avec HER2, par lequel l'activité kinase du partenaire trans-phosphoryle les tyrosines de HER3. Ces tyrosines phosphorylées recrutent PI3K p85 (via les motifs YXXM), Grb2/Shc (MAPK/ERK) et Src, activant les voies de survie et de prolifération cellulaire. HER3 est crucial pour l'organogenèse (développement nerveux et cardiaque), favorise la progression du cancer notamment dans les cancers du sein, de l'ovaire et du poumon, et médie la résistance aux inhibiteurs d'EGFR/HER2 par une signalisation compensatoire.

Informations dutilisation

Application WB, IP Dilution
WB IP
1:1000 1:50
Réactivité Human
Source Rabbit Monoclonal Antibody MW 185 kDa
Tampon de stockage PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN3
Stockage
(À partir de la date de réception)
-20°C (avoid freeze-thaw cycles), 2 years
WB
Experimental Protocol:
 
Sample preparation
1. Tissue: Lyse the tissue sample by adding an appropriate volume of ice-cold RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail),and homogenize the tissue at a low temperature.
2. Adherent cell: Aspirate the culture medium and wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail) and put the sample on ice for 5 min.
3. Suspension cell: Transfer the culture medium to a pre-cooled centrifuge tube. Centrifuge and aspirate the supernatant. Wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail) and put the sample on ice for 5 min.
4. Place the lysate into a pre-cooled microcentrifuge tube. Centrifuge at 4°C for 15 min. Collect the supernatant;
5. Remove a small volume of lysate to determine the protein concentration;
6. Combine the lysate with protein loading buffer. Boil 20 µL sample under 95-100°C for 5 min. Centrifuge for 5 min after cool down on ice.
 
Electrophoretic separation
1. According to the concentration of extracted protein, load appropriate amount of protein sample and marker onto SDS-PAGE gels for electrophoresis. Recommended separating gel (lower gel) concentration: 5%. Reference Table for Selecting SDS-PAGE Separation Gel Concentrations
2. Power up 80V for 30 minutes. Then the power supply is adjusted (110 V~150 V), the Marker is observed, and the electrophoresis can be stopped when the indicator band of the predyed protein Marker where the protein is located is properly separated. (Note that the current should not be too large when electrophoresis, too large current (more than 150 mA) will cause the temperature to rise, affecting the result of running glue. If high currents cannot be avoided, an ice bath can be used to cool the bath.)
 
Transfer membrane
1. Take out the converter, soak the clip and consumables in the pre-cooled converter;
2. Activate PVDF membrane with methanol for 1 min and rinse with transfer buffer;
3. Install it in the order of "black edge of clip - sponge - filter paper - filter paper - glue -PVDF membrane - filter paper - filter paper - sponge - white edge of clip";
4. The protein was electrotransferred to PVDF membrane. ( 0.45 µm PVDF membrane is recommended ) Reference Table for Selecting PVDF Membrane Pore Size Specifications
Recommended conditions for wet transfer: 200 mA, 120 min.
( Note that the transfer conditions can be adjusted according to the protein size. For high-molecular-weight proteins, a higher current and longer transfer time are recommended. However, ensure that the transfer tank remains at a low temperature to prevent gel melting.)
 
Block
1. After electrotransfer, wash the film with TBST at room temperature for 5 minutes;
2. Incubate the film in the blocking solution for 1 hour at room temperature;
3. Wash the film with TBST for 3 times, 5 minutes each time.
 
Antibody incubation
1. Use 5% skim milk powder to prepare the primary antibody working liquid (recommended dilution ratio for primary antibody 1:1000), gently shake and incubate with the film at 4°C overnight;
2. Wash the film with TBST 3 times, 5 minutes each time;
3. Add the secondary antibody to the blocking solution and incubate with the film gently at room temperature for 1 hour;
4. After incubation, wash the film with TBST 3 times for 5 minutes each time.
 
Antibody staining
1. Add the prepared ECL luminescent substrate (or select other color developing substrate according to the second antibody) and mix evenly;
2. Incubate with the film for 1 minute, remove excess substrate (keep the film moist), wrap with plastic film, and expose in the imaging system.

Références

  • https://pubmed.ncbi.nlm.nih.gov/20351256/
  • https://pubmed.ncbi.nlm.nih.gov/20007378/

Données dapplication

WB

Validé par Selleck

  • F4189-wb
    Lane 1: T47D, Lane 2: MCF-7